IMA ImageneBio, Inc.
$4.02▼ -0.74%
Healthcare
Other
Volume 3.7K
Avg Volume (10D) 14.4K
Key Metrics & Fundamentals
Market Cap
$45.72M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.88 - 9.10
% vs 50 MA
-15.55%
% vs 200 MA
-29.11%
RSI-14
33.0
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.98
Free Cash Flow
-$9.07M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$11.61M
COGS
–
Operating Exp
$11.78M
Operating Income
-$11.78M
EBIT
-$11.78M
Pretax Income
-$10.16M
Net Income
-$10.18M
EPS (Diluted)
-0.63
Price & Volume History
Loading chart…
Recent News
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 2, 2026 4:30 PM ET
ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York
GlobeNewswire · Sep 8, 2026 4:30 PM ET
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Aug 17, 2026 4:30 PM ET
ImageneBio Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 5, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Mar 2025
See IMA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.